BSAVBroad-Spectrum Antiviral (BioCryst)
BSAVBovine Serum Albumin Fraction V
References in periodicals archive ?
BCX4430 is the lead compound in BioCryst's broad-spectrum antiviral (BSAV) research programme, which aims to develop broad-spectrum parenteral and oral therapeutics for viruses that pose a threat to national health and security.
The subject of the contract is the conclusion of an insurance contract in the form of a collective agreement to reinsure our defined contribution pension plan (bsav) as at 1.12.2019.
On the other hand, during the Board of Directors, matters related to the economic and financial situation of BSAV have also been addressed, as well as the accounts for the fiscal year of 2017.